Total Payments
$8,690
2024 Payments
$1,071
Companies
37
Transactions
234
Medicare Patients
6,153
Medicare Billing
$363,314
Payment Breakdown by Category
Food & Beverage$6,316 (72.7%)
Consulting$1,400 (16.1%)
Education$624.02 (7.2%)
Other$350.00 (4.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,316 | 189 | 72.7% |
| Consulting Fee | $1,400 | 1 | 16.1% |
| Education | $624.02 | 43 | 7.2% |
| Honoraria | $350.00 | 1 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medline Industries, Inc. | $1,497 | 4 | $0 (2019) |
| AbbVie Inc. | $863.65 | 22 | $0 (2021) |
| Janssen Biotech, Inc. | $802.12 | 38 | $0 (2024) |
| Lilly USA, LLC | $644.36 | 22 | $0 (2022) |
| Biofrontera Inc. | $634.68 | 6 | $0 (2024) |
| LEO Pharma Inc. | $492.29 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $404.89 | 15 | $0 (2023) |
| GENZYME CORPORATION | $344.49 | 4 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $318.94 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $317.09 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,071 | 20 | E.R. Squibb & Sons, L.L.C. ($180.09) |
| 2023 | $793.66 | 16 | Janssen Biotech, Inc. ($213.40) |
| 2022 | $796.78 | 23 | LEO Pharma Inc. ($154.62) |
| 2021 | $428.44 | 21 | AbbVie Inc. ($211.11) |
| 2020 | $477.26 | 15 | AbbVie Inc. ($134.45) |
| 2019 | $1,221 | 37 | GENZYME CORPORATION ($279.56) |
| 2018 | $1,990 | 83 | Biofrontera Inc. ($485.56) |
| 2017 | $1,913 | 19 | Medline Industries, Inc. ($1,478) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.13 | General |
| Category: Immunology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.52 | General |
| Category: Immunology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.31 | General |
| Category: Immunology | ||||||
| 10/30/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.78 | General |
| Category: Immunology | ||||||
| 09/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $116.06 | General |
| Category: DERMATOLOGY | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 08/20/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $112.85 | General |
| Category: DERMATOLOGY | ||||||
| 06/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $51.85 | General |
| Category: Immunology | ||||||
| 05/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $125.71 | General |
| Category: Dermatology | ||||||
| 05/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.38 | General |
| Category: Immunology | ||||||
| 05/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: Dermatology | ||||||
| 04/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Biological) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: CNS | ||||||
| 04/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $131.70 | General |
| Category: Immunology | ||||||
| 03/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Dermatology | ||||||
| 03/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Dermatology | ||||||
| 03/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: DERMATOLOGY | ||||||
| 02/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.27 | General |
| Category: Immunology | ||||||
| 02/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.62 | General |
| 12/12/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Immunology | ||||||
| 11/29/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $89.99 | General |
| Category: Immunology | ||||||
| 11/14/2023 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $114.05 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: DERMATOLOGY | ||||||
| 10/12/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,330 | 2,127 | $265,730 | $84,167 |
| 2022 | 11 | 1,498 | 2,318 | $293,054 | $91,002 |
| 2021 | 11 | 1,499 | 2,405 | $291,639 | $93,132 |
| 2020 | 11 | 1,826 | 2,773 | $308,283 | $95,013 |
Total Patients
6,153
Total Services
9,623
Medicare Billing
$363,314
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 484 | 662 | $115,354 | $36,120 | 31.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 141 | 164 | $35,342 | $11,308 | 32.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 229 | 304 | $39,023 | $11,197 | 28.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 109 | 116 | $22,385 | $7,265 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 60 | $14,828 | $5,552 | 37.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 60 | 60 | $13,027 | $4,040 | 31.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 157 | 650 | $8,177 | $2,826 | 34.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 25 | $8,563 | $2,751 | 32.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 60 | 62 | $6,725 | $2,183 | 32.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 16 | 24 | $2,304 | $924.28 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 530 | 696 | $123,303 | $37,494 | 30.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 189 | 212 | $46,254 | $15,022 | 32.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 255 | 315 | $41,045 | $11,396 | 27.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 126 | 138 | $27,266 | $8,419 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 70 | 70 | $15,376 | $4,635 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 42 | $10,502 | $3,477 | 33.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 170 | 702 | $9,042 | $3,231 | 35.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 71 | 81 | $8,908 | $3,079 | 34.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 17 | 19 | $6,590 | $2,501 | 37.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 21 | 31 | $3,064 | $1,159 | 37.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 12 | 12 | $1,704 | $590.16 | 34.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 526 | 679 | $120,952 | $38,469 | 31.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 189 | 215 | $46,752 | $16,410 | 35.1% |
| 17000 | Destruction of skin growth | Office | 2021 | 249 | 323 | $41,200 | $11,499 | 27.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 132 | 151 | $30,086 | $9,449 | 31.4% |
About Dr. Eliot Mostow, MD
Dr. Eliot Mostow, MD is a Dermatology healthcare provider based in Akron, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376538116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eliot Mostow, MD has received a total of $8,690 in payments from pharmaceutical and medical device companies, with $1,071 received in 2024. These payments were reported across 234 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,316).
As a Medicare-enrolled provider, Mostow has provided services to 6,153 Medicare beneficiaries, totaling 9,623 services with total Medicare billing of $363,314. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Akron, OH
- Active Since 09/19/2005
- Last Updated 09/20/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1376538116
Products in Payments
- TREMFYA (Drug) $584.17
- TALTZ (Drug) $556.80
- Humira (Biological) $518.09
- Ameluz (Drug) $485.56
- ADBRY (Biological) $478.29
- Sotyktu (Drug) $317.09
- Tremfya (Drug) $276.60
- DUPIXENT (Drug) $268.53
- COSENTYX (Biological) $264.64
- STELARA (Biological) $246.24
- OPZELURA (Drug) $231.82
- SKYRIZI (Biological) $187.61
- EPIDUO FORTE (Drug) $158.48
- AMELUZ (Drug) $149.12
- SPEVIGO (Drug) $146.57
- Zoryve (Drug) $142.00
- Santyl (Drug) $121.84
- VYJUVEK (Drug) $114.05
- Cimzia (Drug) $110.18
- TIELLE (Device) $82.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Akron
Dr. Nicholas Nguyen, M.d, M.D
Dermatology — Payments: $11,952
Dermatology $11,952
Raj Patel, Md, MD
Dermatology — Payments: $7,263
Dermatology $7,263
Dr. Julie Mark, Md, MD
Dermatology — Payments: $3,744
Dermatology $3,744
Alexandra Zhang, Md, MD
Dermatology — Payments: $933.19
Dermatology $933.19
Christine Adamick, Md, MD
Dermatology
Dermatology
Linda Alston, Md, MD
Dermatology
Dermatology